Indefinite Delivery Contract SPE2DR25D9304

The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.

The IDC, awarded under the SPE2DB program, covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract enables the DLA to issue firm fixed-price delivery orders for these pharmaceutical items to support the medical supply requirements of Department of Defense (DoD) and other government agency customers globally, including planned and unplanned contingency operations. The contract has a base period of 30 months and three 30-month option periods, aligning with the DLA's larger Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition strategy, which aims to establish multiple regional pharmaceutical prime vendor contracts with an estimated total value of $30.3 billion.